HomeCompareFSKR vs CHD

FSKR vs CHD: Dividend Comparison 2026

FSKR yields 10.20% · CHD yields 1.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FSKR wins by $498951.77M in total portfolio value
10 years
FSKR
FSKR
● Live price
10.20%
Share price
$21.56
Annual div
$2.20
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$498951.80M
Annual income
$489,731,981,317.81
Full FSKR calculator →
CHD
CHD
● Live price
1.28%
Share price
$93.32
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,302.64
Full CHD calculator →

Portfolio growth — FSKR vs CHD

📍 FSKR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSKRCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSKR + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSKR pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSKR
Annual income on $10K today (after 15% tax)
$867.35/yr
After 10yr DRIP, annual income (after tax)
$416,272,184,120.14/yr
CHD
Annual income on $10K today (after 15% tax)
$108.62/yr
After 10yr DRIP, annual income (after tax)
$1,107.24/yr
At 15% tax rate, FSKR beats the other by $416,272,183,012.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSKR + CHD for your $10,000?

FSKR: 50%CHD: 50%
100% CHD50/50100% FSKR
Portfolio after 10yr
$249475.91M
Annual income
$244,865,991,310.22/yr
Blended yield
98.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

FSKR
Analyst Ratings
1
Buy
1
Hold
1
Sell
Consensus: Buy
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+5.4% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSKR buys
0
CHD buys
0
No recent congressional trades found for FSKR or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSKRCHD
Forward yield10.20%1.28%
Annual dividend / share$2.20$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%23.1%
Portfolio after 10y$498951.80M$26.4K
Annual income after 10y$489,731,981,317.81$1,302.64
Total dividends collected$498328.21M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: FSKR vs CHD ($10,000, DRIP)

YearFSKR PortfolioFSKR Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$12,741$2,040.82$10,857$157.30+$1.9KFSKR
2$18,493$4,860.12$11,814$196.49+$6.7KFSKR
3$32,973$13,185.57$12,887$245.97+$20.1KFSKR
4$79,225$43,943.97$14,097$308.68+$65.1KFSKR
5$282,127$197,356.16$15,473$388.49+$266.7KFSKR
6$1,615,525$1,313,649.22$17,046$490.55+$1.60MFSKR
7$15,788,922$14,060,309.92$18,861$621.76+$15.77MFSKR
8$273,744,350$256,850,203.43$20,973$791.47+$273.72MFSKR
9$8,616,652,610$8,323,746,155.53$23,454$1,012.51+$8616.63MFSKR
10$498,951,799,610$489,731,981,317.81$26,398$1,302.64+$498951.77MFSKR

FSKR vs CHD: Complete Analysis 2026

FSKRStock

FS KKR Capital Corp. II, formerly known as FS Investment Corp II, is a business development company specializing in investments in floating rate, senior secured loans-first lien and second line, senior secured bonds, subordinated debt, collateralized securities, corporate bonds, debt securities, equity such as warrants or options in middle market private companies. The fund does not intend to invest to any significant degree in start-up companies, turnaround situations or companies with speculative business plans. It seeks to invest in various sectors such as consumer services, energy, capital goods, software and services, telecommunication services, consumer durables and apparel, diversified financials, materials, automobiles and components, commercial and professional services, media, technology hardware and equipment, health care equipment and services, insurance, retailing, transportation, pharmaceuticals, biotechnology, and life sciences, food and staples retailing, food, beverage, and tobacco, household and personal products, real estate, and utilities. The fund seeks to invest in private companies based in the United States. It also invests in non-U.S. securities, which may include securities denominated in U.S. dollars or in non-U.S. currencies, to the extent permitted by the 1940 Act. The fund purchase interests in loans through secondary market transactions in the ?over-the-counter? market for institutional loans or directly from our target companies. It also purchase minority interests in the form of common or preferred equity in target companies, either in conjunction with one of its debt investments or through a co-investment with a financial sponsor, such as an institutional investor or private equity firm. It may have board representation or board observation rights in its portfolio companies.

Full FSKR Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this FSKR vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSKR vs SCHDFSKR vs JEPIFSKR vs OFSKR vs KOFSKR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.